Shionogi has reached a JPY 151 billion ($1.04 billion) agreement to buy the pharmaceutical subsidiary of Japan Tobacco, Torii ...

With this approval approximately 45 people[i] living with cystic fibrosis, many with a rare mutation, will be newly eligible for a medicine that ...

R&D Day scheduled for June 26, 2025, where Crinetics will provide updates on its early-stage pipeline, with a focus on CRN09682 for neuroendocrine tumors and other SST2+ tumors, TSH antagonist for ...

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative ...

Cysts are small pockets of fluid that form inside the body. Ovarian cysts are common, affecting around one in 10 women. But ...

Therapy should include either belimumab or a calcineurin inhibitor, plus one or more conventional medications such as ...

Sodium bicarbonate has some down sides, but there are suitable alternatives, including increased intake of fruits and vegetables and sodium citrate. Metabolic acidosis is a common yet often overlooked ...

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...

In a new study led by the UCLA Health Jonsson Comprehensive Cancer Center, investigators show that using advanced MRI imaging ...

COVID-19 is the disease caused by SARS-CoV-2 ... lasting lung and heart muscle damage, nervous system problems, kidney failure or death. If you have a fever or any of the symptoms listed above, call ...